v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2020
Jun. 30, 2020
Current assets:    
Cash $ 8,360 $ 197,622
Accounts receivable – net 65,053 61,013
Inventories 213,384 275,605
Other current assets 272,032 398,085
Total current assets 558,829 932,325
Total assets 558,829 932,325
Current liabilities:    
Accounts payable 1,147,502 1,286,149
Accrued expense-related party 9,974 9,974
Accrued expense 56,923
Accrued interest 214,402 192,625
Short term borrowings - line of credit 2,794 3,897
Convertible notes payable - net of discount 2,348,239 2,330,189
Fair value of derivative liabilities 1,357,245 1,590,638
Total current liabilities 5,137,079 5,413,472
Commitments and contingencies
Stockholders' deficit:    
Preferred stock, ($0.001 par value, 1,000,000 shares authorized, and 1,000 issued and outstanding as of September 30, 2020 and 1,000 outstanding as of June 30, 2020, respectively) 1 1
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 65,085,597 issued and outstanding as of September 30, 2020 and 61,796,680 outstanding as of June 30, 2020, respectively) 65,086 61,797
Additional paid in capital 13,931,609 13,088,177
Accumulated deficit (18,574,946) (17,631,122)
Total stockholders' deficit (4,578,250) (4,481,147)
Total Liabilities and Stockholders' Deficit $ 558,829 $ 932,325

Source